Harmony Biosciences Holdings (HRMY) EBITDA Margin (2020 - 2026)
Harmony Biosciences Holdings' EBITDA Margin was 36.47% in Q2 2026, up 9.46 percentage points from 27.01% a year earlier and up 16.38 percentage points from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Harmony Biosciences Holdings' EBITDA Margin was 26.67% through Jun 30, 2026, down 5.14 percentage points year-over-year; for FY2025, it came in at 26.92%, down 3.15 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +9.88 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 30.07% in FY2024 (-7.11 pp), 37.18% in FY2023 (+4.39 pp), 32.79% in FY2022 (-2.03 pp) and 34.82% in FY2021 (+17.78 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q1 2024.
- Compared with a year earlier, EBITDA Margin was higher in three of the last eight quarters, with an average year-over-year change of -2.47 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 28.73 percentage points); the worst was Q2 2024 (a drop of 23.60 percentage points).
- Per Business Quant data, HRMY's EBITDA Margin in the three quarters before Q2 2026 was 20.08% (Q1 2026), 18.87% (Q4 2025) and 29.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -474.81 Mn | 198.08 Mn | 36.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.47% |
| Mar 31, 2026 | 20.08% |
| Dec 31, 2025 | 18.87% |
| Sep 30, 2025 | 29.84% |
| Jun 30, 2025 | 27.01% |
| Mar 31, 2025 | 33.68% |
| Dec 31, 2024 | 30.65% |
| Sep 30, 2024 | 36.38% |
| Jun 30, 2024 | 15.86% |
| Mar 31, 2024 | 37.61% |
| Dec 31, 2023 | 27.50% |
| Sep 30, 2023 | 44.06% |
| Jun 30, 2023 | 39.46% |
| Mar 31, 2023 | 39.02% |
| Dec 31, 2022 | 41.84% |
| Sep 30, 2022 | 15.33% |
| Jun 30, 2022 | 36.60% |
| Mar 31, 2022 | 38.39% |
| Dec 31, 2021 | 36.61% |
| Sep 30, 2021 | 31.86% |
API Access
Harmony Biosciences Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();